REGULATION OF FAS-MEDIATED APOPTOSIS IN B CELLS
FAS 介导的 B 细胞凋亡的调节
基本信息
- 批准号:2457884
- 负责人:
- 金额:$ 25.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-08-01 至 1999-07-31
- 项目状态:已结题
- 来源:
- 关键词:B lymphocyte CD antigens T lymphocyte anergy antiantibody apoptosis autoantibody autoimmunity biological signal transduction cell mediated lymphocytolysis test ceramides endopeptidases enzyme activity gene expression genetically modified animals interleukin 4 laboratory mouse lymphokines phosphorylation protein biosynthesis protein kinase C tyrosine western blottings
项目摘要
DESCRIPTION (Adapted from the Applicant's Abstract): B-cell anergy is one
mechanism utilized to expunge autoreactive immunoglobulin specificities.
Anergic B-cells survive in a state of diminished antigen receptor
responsiveness, and are deleted by Fas-mediated apoptosis induced by T
effector cells. In normal B-cells sensitivity to Fas-directed cell death
can be regulated by IL-4R and sIg signals that produce a state of
Fas-resistance. The hypothesis guiding this study is that anergic B-cells
may, as a result of specific immune signals, become resistant to
Fas-mediated apoptosis, thereby avoiding elimination and presenting the
potential for subsequent activation and autoantibody production. Elements
of this hypothesis have ramifications for B-cell immunocompetence and the
regulation of apoptosis in general. For this reason, and because so little
is known about the means by which Fas-resistance is triggered and
established, it is proposed to explore protection against Fas-directed cell
death in 3 stages. 1) Evaluate the capacity of IL-4 to oppose Fas-mediated
apoptosis by anti-Ig, and determine the role of other T-cell-derived
lymphokines, using standard cytotoxicity assays. 2) Determine the metabolic
level at which resistance to Fas-mediated apoptosis is produced by IL-4 and
by anti-Ig, by examining Fas-triggered events of protein tyrosine
phosphorylation, ceramide production, and protease activation, using Western
blotting, identification of radiolabeled lipids, and enzymatic assays of
protein digestion, and evaluate the role of Bcl-x, through tests of gene and
protein expression, and evaluation of overexpressing transgenic animals. 3)
Assess induction of Fas-resistance in anergic B-cells derived from double
transgenic mice, and monitor autoantibodies rescued through somatic cell
hybridization of B-cells from normal animals in which resistance is
generated in vitro. This work should lead to a fuller understanding of the
signals and mechanisms that produce B-cell resistance to Fas-mediated
apoptosis, and validate or refute the hypothesis described above, which has
important implications for the pathogenesis of serological autoimmunity.
描述(改编自申请人的摘要):B 细胞无反应性是一种
用于消除自身反应性免疫球蛋白特异性的机制。
无能 B 细胞在抗原受体减少的状态下存活
响应性,并被 T 诱导的 Fas 介导的细胞凋亡删除
效应细胞。 正常 B 细胞对 Fas 引导的细胞死亡敏感
可以通过 IL-4R 和 sIg 信号调节,从而产生以下状态:
Fas 抗性。 指导这项研究的假设是无能 B 细胞
由于特定的免疫信号,可能会产生耐药性
Fas 介导的细胞凋亡,从而避免消除并呈现
随后激活和自身抗体产生的潜力。 元素
该假设对 B 细胞免疫能力和
细胞凋亡的一般调节。 正因为如此,也因为如此之少
了解触发 Fas 抗性的方式,并且
建立后,建议探索针对 Fas 定向细胞的保护
死亡分3个阶段。 1)评估IL-4对抗Fas介导的能力
抗 Ig 导致细胞凋亡,并确定其他 T 细胞来源的作用
淋巴因子,使用标准细胞毒性测定。 2) 确定代谢
IL-4 和 IL-4 对 Fas 介导的细胞凋亡产生抗性的水平
通过抗 Ig,通过检查 Fas 触发的蛋白质酪氨酸事件
使用 Western 进行磷酸化、神经酰胺生成和蛋白酶激活
印迹、放射性标记脂质的鉴定以及酶测定
蛋白质消化,并通过基因测试和评估Bcl-x的作用
蛋白质表达,以及过度表达转基因动物的评估。 3)
评估源自双核细胞的无能 B 细胞对 Fas 抗性的诱导
转基因小鼠,并监测通过体细胞拯救的自身抗体
正常动物的 B 细胞杂交,其中抗性
体外产生。 这项工作应该使人们对
产生 B 细胞对 Fas 介导的抗性的信号和机制
细胞凋亡,并验证或反驳上述假设,该假设
对血清学自身免疫的发病机制具有重要意义。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
THOMAS L ROTHSTEIN其他文献
THOMAS L ROTHSTEIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('THOMAS L ROTHSTEIN', 18)}}的其他基金
Human B1-like Cells and Pneumococcal Defense in the Elderly
人类 B1 样细胞和老年人的肺炎球菌防御
- 批准号:
10553643 - 财政年份:2019
- 资助金额:
$ 25.26万 - 项目类别:
Human B1-like Cells and Pneumococcal Defense in the Elderly
人类 B1 样细胞和老年人的肺炎球菌防御
- 批准号:
10330573 - 财政年份:2019
- 资助金额:
$ 25.26万 - 项目类别:
IgM vs IgG natural antibodies that bind pathogenic apolipoprotein B100
结合致病性载脂蛋白 B100 的 IgM 与 IgG 天然抗体
- 批准号:
9305007 - 财政年份:2016
- 资助金额:
$ 25.26万 - 项目类别:
相似海外基金
Analysis of expression of Cd antigens in retinoblastoma, and its application for disease classification and therapeutic strategy
视网膜母细胞瘤中Cd抗原的表达分析及其在疾病分类和治疗策略中的应用
- 批准号:
25670726 - 财政年份:2013
- 资助金额:
$ 25.26万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research














{{item.name}}会员




